Word

TRANSINE

Status

Registered

Status Code

700

Status Date

Tuesday, August 16, 2022

Serial Number

79316838

Registration Number

6816931

Registration Date

Tuesday, August 16, 2022

Mark Type

4000

Filing Date

Thursday, February 11, 2021

Published for Opposition

Tuesday, May 31, 2022

Trademark Owner History

Harness Therapeutics Limited - Original Registrant
Transine Therapeutics Limited - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DNA and RNA, namely, nucleic acid sequences for medical purposes

1 Chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use

42 Scientific and technological services and research and design relating thereto, namely scientific research services in the field of genomics; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; scientific research into DNA and RNA; research and development into the creation of DNA and RNA; research, development, testing and analysis for scientific research purposes in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene editing services for scientific research purposes; DNA and RNA modelling services, namely genetic mapping for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating and providing databases or collections of information on normal and mutated genes for scientific research purposes; scientific services relating to the discovery, preclinical and clinical development of therapeutic products, namely therapeutic DNA and RNA; consultancy and advisory services relating to the aforesaid services; research and development of synthetic DNA, RNA, genes and oligonucleotides for others

Trademark Events

Mar 2, 2024

Change Of Name/Address Rec'd From Ib

Dec 21, 2022

Final Decision Transaction Processed By Ib

Nov 26, 2022

Final Disposition Notice Sent To Ib

Nov 26, 2022

Final Disposition Processed

Nov 16, 2022

Final Disposition Notice Created, To Be Sent To Ib

Oct 26, 2022

Limitation From The Ib Examined, No Action Is Needed

Aug 16, 2022

Notice Of Registration Confirmation Emailed

Aug 16, 2022

Registered-Principal Register

Jun 20, 2022

Limitation Of Goods Received From Ib

May 31, 2022

Official Gazette Publication Confirmation E-Mailed

May 31, 2022

Published For Opposition

May 11, 2022

Notification Of Notice Of Publication E-Mailed

Apr 25, 2022

Assigned To Lie

Apr 22, 2022

Approved For Pub - Principal Register

Mar 25, 2022

Assigned To Examiner

Mar 16, 2022

Teas/Email Correspondence Entered

Mar 15, 2022

Correspondence Received In Law Office

Mar 15, 2022

Teas Response To Office Action Received

Oct 4, 2021

Refusal Processed By Ib

Sep 16, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Sep 16, 2021

Refusal Processed By Mpu

Sep 2, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Sep 1, 2021

Non-Final Action Written

Aug 27, 2021

Non-Final Action (Ib Refusal) Withdrawn For Review

Aug 13, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Aug 12, 2021

Non-Final Action Written

Aug 10, 2021

Application Filing Receipt Mailed

Aug 9, 2021

Assigned To Examiner

Aug 5, 2021

New Application Office Supplied Data Entered

Jul 29, 2021

Sn Assigned For Sect 66a Appl From Ib